Accelerated progression of multiple myeloma during anti-CD20 (Rituximab) therapy

被引：14
作者：
Korte, W
Jost, C
Cogliatti, S
Hess, U
Cerny, T [1 ]
机构：
[1] Kantonsspital, Div Med Oncol, CH-9007 St Gallen, Switzerland
[2] Kantonsspital, Inst Clin Chem & Haematol, CH-9007 St Gallen, Switzerland
[3] Kantonsspital, Inst Pathol, CH-9007 St Gallen, Switzerland
来源：
ANNALS OF ONCOLOGY | 1999年 / 10卷 / 10期
关键词：
CD20; IL-6; monitoring; multiple myeloma;
D O I：
10.1023/A:1008310819049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1249 / 1250
页数：2
相关论文
共 50 条
[21]   Targeted therapy for multiple myeloma: an overview on CD138-based strategies [J].
Riccardi, Federico ;
Tangredi, Carmela ;
Dal Bo, Michele ;
Toffoli, Giuseppe .
FRONTIERS IN ONCOLOGY, 2024, 14
[22]   CD73 Dysregulates Monocyte Anti-Tumor Activity in Multiple Myeloma [J].
Zhou, Lin ;
Liu, XiaoLan ;
Guan, Tao ;
Xu, HaiLing ;
Wei, Fang .
CANCER MANAGEMENT AND RESEARCH, 2023, 15 :729-738
[23]   Anti-BCMA Therapy in Multiple Myeloma: A Single-Center Experience [J].
Puertas, Borja ;
Fernandez, Adolfo ;
Jara, Mirian ;
Hernandez, Alberto ;
Gomez, Sandra ;
Alejo, Elena ;
Maria Navarro, Jose ;
Alonso, David ;
Fonseca, Marta ;
Rey, Beatriz ;
Avendano, Alejandro ;
Baile, Monica ;
Cabero, Almudena ;
Cabrero, Monica ;
Lopez, Miriam ;
Perez, Estefania ;
Martin, Ana ;
Lopez, Lucia ;
Puig, Noemi ;
Gonzalez-Calle, Veronica ;
Victoria Mateos, Maria .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 :S413-S413
[24]   Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report [J].
Shoko Sakano ;
Hirofumi Matsuyama ;
Hidehiro Ishikawa ;
Akihiro Shindo ;
Yuichiro Ii ;
Keita Matsuura ;
Minoru Mizutani ;
Norikazu Kawada ;
Hidekazu Tomimoto .
BMC Neurology, 20
[25]   Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report [J].
Sakano, Shoko ;
Matsuyama, Hirofumi ;
Ishikawa, Hidehiro ;
Shindo, Akihiro ;
Ii, Yuichiro ;
Matsuura, Keita ;
Mizutani, Minoru ;
Kawada, Norikazu ;
Tomimoto, Hidekazu .
BMC NEUROLOGY, 2020, 20 (01)
[26]   Rapid growth of glioblastoma during therapy for multiple myeloma: case report [J].
Sonoda, Y ;
Kumabe, T ;
Umezawa, K ;
Shimizu, H ;
Murakawa, Y ;
Kanamaru, R ;
Yoshimoto, T .
NEUROLOGICAL SURGERY, 1998, 26 (08) :737-741
[27]   Listeria monocytogenes Bacteremia During Isatuximab Therapy in a Patient with Multiple Myeloma [J].
Ueno, Toshiyuki ;
Ohta, Takanori ;
Imanaga, Hiroshi ;
Nakazawa, Megumi ;
Sato, Yoriko ;
Sugio, Yasuhiro ;
Uchida, Yujiro ;
Ohno, Yuju ;
Uehara, Yasufumi .
INTERNAL MEDICINE, 2021, 60 (22) :3605-3608
[28]   CD20-directed serotherapy in patients with multiple myeloma: Biologic considerations and therapeutic applications [J].
Treon, SP ;
Pilarski, TM ;
Belch, TR ;
Kelliher, A ;
Preffer, FI ;
Shima, Y ;
Mitsiades, CS ;
Mitsiades, NS ;
Szczepek, AJ ;
Ellman, L ;
Harmon, D ;
Grossbard, ML ;
Anderson, KC .
JOURNAL OF IMMUNOTHERAPY, 2002, 25 (01) :72-81
[29]   A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma [J].
Candelaria, Pierre V. ;
Nava, Miguel ;
Daniels-Wells, Tracy R. ;
Penichet, Manuel L. .
CANCERS, 2023, 15 (18)
[30]   A bibliometric analysis of CD38-targeting antibody therapy in multiple myeloma from [J].
Ding, Hanyi ;
Zhang, Xiaoyuan ;
Gang, Dongxu ;
He, Xiaoyu ;
Jiang, Songfu .
TRANSLATIONAL CANCER RESEARCH, 2022, 11 (04) :772-783
12345